Rajvir Dahiya

DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer.

DNA methyltransferase and demethylase in human prostate cancer.

Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.

Effects of aging on growth factors gene and protein expression in the dorsal and ventral lobes of rat prostate.

Transforming growth factor-beta(s) and their receptors in aging rat prostate.

The bladder acellular matrix graft in a rat chemical cystitis model: functional and histologic evaluation.

Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer.

CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.

Single nucleotide polymorphisms of estrogen receptor alpha in human renal cell carcinoma.

Homologous acellular matrix graft for vaginal repair in rats: a pilot study for a new reconstructive approach.

Polymorphisms of estrogen receptor alpha gene in endometrial cancer.

Beta-catenin mutations correlate with over expression of C-myc and cyclin D1 Genes in bladder cancer.

Loss of anti-apoptotic genes in aging rat crura.

MethPrimer: designing primers for methylation PCRs.

Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1.

PGDB: a curated and integrated database of genes related to the prostate.

Hormonal, cellular, and molecular control of prostatic development.

Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.

Spontaneous mutation in mice provides new insight into the genetic mechanisms that pattern the seminal vesicles and prostate gland.

The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients.

Estrogen receptor alpha polymorphisms and renal cell carcinoma--a possible risk.

CYP1B1 gene in endometrial cancer.

Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers.

DNA mismatch repair genes in renal cell carcinoma.

The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.

Diabetes induced erectile dysfunction and apoptosis in penile crura are recovered by insulin treatment in rats.

Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.

CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions.

Polymorphisms of estrogen receptor alpha in prostate cancer.

Six polymorphisms on estrogen receptor 1 gene in Japanese, American and German populations.

Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation.

Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF.

Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.

The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations.

Alleles of polymorphic sites that correspond to hyperactive variants of CYP1B1 protein are significantly less frequent in Japanese as compared to American and German populations.

Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer.

Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.

Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.

CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.

Age-dependent methylation of ESR1 gene in prostate cancer.

Distribution of a single nucleotide polymorphism on codon 211 of the androgen receptor gene and its correlation with human renal cell cancer in Japanese patients.

DNA methylation in prostate cancer.

Human papilloma virus type 16 infection and the early onset of cervical cancer.

Kidney gene database: a curated and integrated database of genes involved in kidney disease.

Inactivation of the hMSH3 mismatch repair gene in bladder cancer.

Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura.

Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatment.

Epigenetic changes in prostate cancer: implication for diagnosis and treatment.

Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.

Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.

GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients.

Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.

Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.

CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.

Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: histologic and functional evaluation.

Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.

Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer.

WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma.

Multigene methylation analysis for detection and staging of prostate cancer.

Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.

Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.

Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat.

Collagen I:III ratio in canine heterologous bladder acellular matrix grafts.

Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.

Polymorphisms of DNA repair genes are associated with renal cell carcinoma.

Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.

The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men.

Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer.

Small dsRNAs induce transcriptional activation in human cells.

Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.

Polymorphisms of DNA repair genes are risk factors for prostate cancer.

Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer.

Functional improvement in spinal cord injury-induced neurogenic bladder by bladder augmentation using bladder acellular matrix graft in the rat.

A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins.

Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer.

Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer.

MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.

CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.

A dioxin-responsive enhancer 3' of the human CYP1A2 gene.

MicroRNA-373 induces expression of genes with complementary promoter sequences.

CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.

COMT polymorphisms affecting protein expression are risk factors for endometrial cancer.

Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells.

Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer.

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.

Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification.

Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.

Frizzled-7 as a potential therapeutic target in colorectal cancer.

Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function.

Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder.

BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.

Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention.

Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.

Double stranded-RNA-mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma.

The bcl2 -938CC genotype has poor prognosis and lower survival in renal cancer.

Wnt antagonist gene polymorphisms and renal cancer.

Functional significance of cytochrome P450 1B1 in endometrial carcinogenesis.

Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.

Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.

Restoring erectile function by antioxidant therapy in diabetic rats.

Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer.

Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.

Role of secreted frizzled-related protein 3 in human renal cell carcinoma.

Diet, microRNAs and prostate cancer.

Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.

Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer.

Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer.

Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.

Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer.

MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer.

Cytochrome P450 17 (CYP17) is involved in endometrial cancinogenesis through apoptosis and invasion pathways.

A heart with 67 stents.

MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.

IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.

Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.

MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.

MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer.

DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma.

Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells.

Graded activation of the MEK1/MT1-MMP axis determines renal epithelial cell tumor phenotype.

The complex roles of Wnt antagonists in RCC.

MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.

Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4.

MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.

Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.

Possible involvement of Wnt11 in colorectal cancer progression.

MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.

MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells.

Wnt signaling pathways in urological cancers: past decades and still growing.

Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

miRNA-708 control of CD44(+) prostate cancer-initiating cells.

5-Aza-2'-deoxycytidine stress response and apoptosis in prostate cancer.

Frizzled homolog proteins, microRNAs and Wnt signaling in cancer.

Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151.

Simultaneous implantation of bilateral ureters into bladder acellular matrix graft after partial cystectomy in a porcine model.

MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer.

miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.

Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.

Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.

MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer.

Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.

Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells.

MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.

Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.

MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases.

Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells.

Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.

Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.

Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.

Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways.

Versican is a potential therapeutic target in docetaxel-resistant prostate cancer.

Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma.

Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.

CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma.

Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.

MicroRNA-720 Regulates E-cadherin-αE-catenin Complex and Promotes Renal Cell Carcinoma.

MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.

Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished Expression.